consensus on blood pressure management in Parkinson's disease (the 2nd version)

Title: consensus on blood pressure management in Parkinson's disease (the 2nd version)
Edition: Adapted
Classification: Experts consensus
Field: Diagnosis and Treatment
Countries and regions: China
Guidelines users: clinicians, including neurologist, cardiologist and movement disorders specialists
Evidence classification method: Definitions for specific recommendations Goetz C. Movement disorders : official journal of the Movement Disorder Society (2002):
Development unit: Ruijin Hospital Affiliated To Shanghai Jiao Tong University School of Medicine
Registration time: 2022-10-08
Registration number: PREPARE-2022CN636
Purpose of the guideline: The fact that effects of Parkinson’s disease (PD)on multi-system was more and more realized. Blood pressure dysfunction represented by orthostatic hypotension(OH) was one of the common non-motor symptoms. It can occur in any stage of PD, and was not only caused by autonomic dysfunction but by PD medicine. Blood pressure dysfunction in PD was associated with poor quality of life. Unfortunately, about 20~50% of PD patients had blood pressure dysfunction, including OH, supine hypertension (SH), postprandial hypotension (PPH), and the dysfunction would be aggravated after PD medicine, leading to adverse events including falls, syncope, stroke and so on. The original version of consensus on blood pressure management in Parkinson's disease was firstly developed in 2020 in China based on research and clinical experience from experts. Now, we are aiming the second version concensus with revisement and update based on original version.